PUBLISHER: KBV Research | PRODUCT CODE: 1292550
PUBLISHER: KBV Research | PRODUCT CODE: 1292550
Europe Antacids Market Size, Share & Industry Trends Analysis Report By Formulation Type (Tablets, Liquids and Others), By Mechanism of Action (Non-systemic and Systemic), By Distribution Channel, By Country and Growth Forecast, 2023 - 2029
The Europe Antacids Market would witness market growth of 3.0% CAGR during the forecast period (2023-2029).
The incidence of mid and early-life deaths is anticipated to drop significantly due to advancements in sanitation, immunization, and other areas. As a result, the senior population uses antacids more frequently. In addition, because of people's reliance on packaged foods as a result of a busy lifestyle, the use of antacids has increased. Fast food, which contains specific preservatives that disrupt digestion and chemicals that cause heartburn, further increases the need for antacids. The demand for acid-regulating medicines is also strengthened by the lack of physical activity, causing obesity as well as chronic gastrointestinal diseases.
The regional antacid market is anticipated to continue to experience rapid growth. This growth is attributed to the region's rising incidence of gastrointestinal diseases and its cutting-edge therapeutic and diagnostic facilities. As a result, antacids are widely available as over-the-counter medications at many brand-name retailers in the region and are in high demand. Another driving force behind the expansion of the European market is the expansion of online pharmacies and the e-commerce industry, which together are helping to meet demand.
Men outweigh women in Italy, where 64.5% of adults over 11 have consumed alcohol at least once, according to a 2015 Ministry of Health study. Among those between 11 and 24 ages, regular alcohol consumption outside of meals was also seen. The market's growth is anticipated to be fueled by the increased prevalence of gastrointestinal conditions such as gastroesophageal reflux and rising alcohol use.
The Germany market dominated the Europe Antacids Market by Country in 2022, and would continue to be a dominant market till 2029; thereby, achieving a market value of $530.3 Million by 2029. The UK market is anticipated to grow at a CAGR of 2.2% during (2023 - 2029). Additionally, The France market would exhibit a CAGR of 3.8% during (2023 - 2029).
Based on Formulation Type, the market is segmented into Tablets, Liquids and Others. Based on Mechanism of Action, the market is segmented into Non-systemic and Systemic. Based on Distribution Channel, the market is segmented into Drug Store & Retail Pharmacies, Hospital Pharmacies and Online Pharmacies. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Alkem Laboratories Ltd., Bayer AG, Cipla Limited, Pfizer, Inc., Prestige Consumer Healthcare, Inc., Reckitt Benckiser Group PLC, WellSpring Pharmaceutical Corporation (Avista Capital Partners), Sanofi S.A. and Sun Pharmaceutical Industries Ltd.
Scope of the Study
Market Segments covered in the Report:
By Formulation Type
- Tablets
- Liquids
- Others
By Mechanism of Action
- Non-systemic
- Systemic
By Distribution Channel
- Drug Store & Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Companies Profiled
- Abbott Laboratories
- Alkem Laboratories Ltd.
- Bayer AG
- Cipla Limited
- Pfizer, Inc.
- Prestige Consumer Healthcare, Inc.
- Reckitt Benckiser Group PLC
- WellSpring Pharmaceutical Corporation (Avista Capital Partners)
- Sanofi S.A.
- Sun Pharmaceutical Industries Ltd.
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Europe Antacids Market, by Formulation Type
- 1.4.2 Europe Antacids Market, by Mechanism of Action
- 1.4.3 Europe Antacids Market, by Distribution Channel
- 1.4.4 Europe Antacids Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market Composition & Scenario
- 2.1.1 Overview
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
Chapter 3. Europe Antacids Market by Formulation Type
- 3.1 Europe Tablets Market by Country
- 3.2 Europe Liquids Market by Country
- 3.3 Europe Others Market by Country
Chapter 4. Europe Antacids Market by Mechanism of Action
- 4.1 Europe Non-systemic Market by Country
- 4.2 Europe Systemic Market by Country
Chapter 5. Europe Antacids Market by Distribution Channel
- 5.1 Europe Drug Store & Retail Pharmacies Market by Country
- 5.2 Europe Hospital Pharmacies Market by Country
- 5.3 Europe Online Pharmacies Market by Country
Chapter 6. Europe Antacids Market by Country
- 6.1 Germany Antacids Market
- 6.1.1 Germany Antacids Market by Formulation Type
- 6.1.2 Germany Antacids Market by Mechanism of Action
- 6.1.3 Germany Antacids Market by Distribution Channel
- 6.2 UK Antacids Market
- 6.2.1 UK Antacids Market by Formulation Type
- 6.2.2 UK Antacids Market by Mechanism of Action
- 6.2.3 UK Antacids Market by Distribution Channel
- 6.3 France Antacids Market
- 6.3.1 France Antacids Market by Formulation Type
- 6.3.2 France Antacids Market by Mechanism of Action
- 6.3.3 France Antacids Market by Distribution Channel
- 6.4 Russia Antacids Market
- 6.4.1 Russia Antacids Market by Formulation Type
- 6.4.2 Russia Antacids Market by Mechanism of Action
- 6.4.3 Russia Antacids Market by Distribution Channel
- 6.5 Spain Antacids Market
- 6.5.1 Spain Antacids Market by Formulation Type
- 6.5.2 Spain Antacids Market by Mechanism of Action
- 6.5.3 Spain Antacids Market by Distribution Channel
- 6.6 Italy Antacids Market
- 6.6.1 Italy Antacids Market by Formulation Type
- 6.6.2 Italy Antacids Market by Mechanism of Action
- 6.6.3 Italy Antacids Market by Distribution Channel
- 6.7 Rest of Europe Antacids Market
- 6.7.1 Rest of Europe Antacids Market by Formulation Type
- 6.7.2 Rest of Europe Antacids Market by Mechanism of Action
- 6.7.3 Rest of Europe Antacids Market by Distribution Channel
Chapter 7. Company Profiles
- 7.1 Abbott Laboratories
- 7.1.1 Company Overview
- 7.1.2 Financial Analysis
- 7.1.3 Segmental and Regional Analysis
- 7.1.4 Research & Development Expense
- 7.1.5 SWOT Analysis
- 7.2 Alkem Laboratories Ltd.
- 7.2.1 Company Overview
- 7.2.2 Financial Analysis
- 7.2.3 Regional Analysis
- 7.2.4 Research & Development Expenses
- 7.3 Bayer AG
- 7.3.1 Company Overview
- 7.3.2 Financial Analysis
- 7.3.3 Segmental and Regional Analysis
- 7.3.4 Research & Development Expense
- 7.3.5 SWOT Analysis
- 7.4 Cipla Limited
- 7.4.1 Company Overview
- 7.4.2 Financial Analysis
- 7.4.3 Regional Analysis
- 7.4.4 Research & Development Expense
- 7.5 Pfizer, Inc.
- 7.5.1 Company Overview
- 7.5.2 Financial Analysis
- 7.5.3 Regional & Segmental Analysis
- 7.5.4 Research & Development Expense
- 7.6 Prestige Consumer Healthcare, Inc.
- 7.6.1 Company Overview
- 7.6.2 Financial Analysis
- 7.6.3 Segmental and Regional Analysis
- 7.7 Reckitt Benckiser Group PLC
- 7.7.1 Company Overview
- 7.7.2 Financial Analysis
- 7.7.3 Segmental and Regional Analysis
- 7.7.4 Research & Development Expenses
- 7.8 WellSpring Pharmaceutical Corporation (Avista Capital Partners)
- 7.8.1 Company Overview
- 7.9 Sanofi S.A.
- 7.9.1 Company Overview
- 7.9.2 Financial Analysis
- 7.9.3 Segmental and Regional Analysis
- 7.9.4 Research & Development Expense
- 7.10. Sun Pharmaceutical Industries Ltd.
- 7.10.1 Company Overview
- 7.10.2 Financial Analysis
- 7.10.3 Regional Analysis
- 7.10.4 Research & Development Expenses
LIST OF TABLES
- TABLE 1 Europe Antacids Market, 2019 - 2022, USD Million
- TABLE 2 Europe Antacids Market, 2023 - 2029, USD Million
- TABLE 3 Europe Antacids Market by Formulation Type, 2019 - 2022, USD Million
- TABLE 4 Europe Antacids Market by Formulation Type, 2023 - 2029, USD Million
- TABLE 5 Europe Tablets Market by Country, 2019 - 2022, USD Million
- TABLE 6 Europe Tablets Market by Country, 2023 - 2029, USD Million
- TABLE 7 Europe Liquids Market by Country, 2019 - 2022, USD Million
- TABLE 8 Europe Liquids Market by Country, 2023 - 2029, USD Million
- TABLE 9 Europe Others Market by Country, 2019 - 2022, USD Million
- TABLE 10 Europe Others Market by Country, 2023 - 2029, USD Million
- TABLE 11 Europe Antacids Market by Mechanism of Action, 2019 - 2022, USD Million
- TABLE 12 Europe Antacids Market by Mechanism of Action, 2023 - 2029, USD Million
- TABLE 13 Europe Non-systemic Market by Country, 2019 - 2022, USD Million
- TABLE 14 Europe Non-systemic Market by Country, 2023 - 2029, USD Million
- TABLE 15 Europe Systemic Market by Country, 2019 - 2022, USD Million
- TABLE 16 Europe Systemic Market by Country, 2023 - 2029, USD Million
- TABLE 17 Europe Antacids Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 18 Europe Antacids Market by Distribution Channel, 2023 - 2029, USD Million
- TABLE 19 Europe Drug Store & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
- TABLE 20 Europe Drug Store & Retail Pharmacies Market by Country, 2023 - 2029, USD Million
- TABLE 21 Europe Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
- TABLE 22 Europe Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
- TABLE 23 Europe Online Pharmacies Market by Country, 2019 - 2022, USD Million
- TABLE 24 Europe Online Pharmacies Market by Country, 2023 - 2029, USD Million
- TABLE 25 Europe Antacids Market by Country, 2019 - 2022, USD Million
- TABLE 26 Europe Antacids Market by Country, 2023 - 2029, USD Million
- TABLE 27 Germany Antacids Market, 2019 - 2022, USD Million
- TABLE 28 Germany Antacids Market, 2023 - 2029, USD Million
- TABLE 29 Germany Antacids Market by Formulation Type, 2019 - 2022, USD Million
- TABLE 30 Germany Antacids Market by Formulation Type, 2023 - 2029, USD Million
- TABLE 31 Germany Antacids Market by Mechanism of Action, 2019 - 2022, USD Million
- TABLE 32 Germany Antacids Market by Mechanism of Action, 2023 - 2029, USD Million
- TABLE 33 Germany Antacids Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 34 Germany Antacids Market by Distribution Channel, 2023 - 2029, USD Million
- TABLE 35 UK Antacids Market, 2019 - 2022, USD Million
- TABLE 36 UK Antacids Market, 2023 - 2029, USD Million
- TABLE 37 UK Antacids Market by Formulation Type, 2019 - 2022, USD Million
- TABLE 38 UK Antacids Market by Formulation Type, 2023 - 2029, USD Million
- TABLE 39 UK Antacids Market by Mechanism of Action, 2019 - 2022, USD Million
- TABLE 40 UK Antacids Market by Mechanism of Action, 2023 - 2029, USD Million
- TABLE 41 UK Antacids Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 42 UK Antacids Market by Distribution Channel, 2023 - 2029, USD Million
- TABLE 43 France Antacids Market, 2019 - 2022, USD Million
- TABLE 44 France Antacids Market, 2023 - 2029, USD Million
- TABLE 45 France Antacids Market by Formulation Type, 2019 - 2022, USD Million
- TABLE 46 France Antacids Market by Formulation Type, 2023 - 2029, USD Million
- TABLE 47 France Antacids Market by Mechanism of Action, 2019 - 2022, USD Million
- TABLE 48 France Antacids Market by Mechanism of Action, 2023 - 2029, USD Million
- TABLE 49 France Antacids Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 50 France Antacids Market by Distribution Channel, 2023 - 2029, USD Million
- TABLE 51 Russia Antacids Market, 2019 - 2022, USD Million
- TABLE 52 Russia Antacids Market, 2023 - 2029, USD Million
- TABLE 53 Russia Antacids Market by Formulation Type, 2019 - 2022, USD Million
- TABLE 54 Russia Antacids Market by Formulation Type, 2023 - 2029, USD Million
- TABLE 55 Russia Antacids Market by Mechanism of Action, 2019 - 2022, USD Million
- TABLE 56 Russia Antacids Market by Mechanism of Action, 2023 - 2029, USD Million
- TABLE 57 Russia Antacids Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 58 Russia Antacids Market by Distribution Channel, 2023 - 2029, USD Million
- TABLE 59 Spain Antacids Market, 2019 - 2022, USD Million
- TABLE 60 Spain Antacids Market, 2023 - 2029, USD Million
- TABLE 61 Spain Antacids Market by Formulation Type, 2019 - 2022, USD Million
- TABLE 62 Spain Antacids Market by Formulation Type, 2023 - 2029, USD Million
- TABLE 63 Spain Antacids Market by Mechanism of Action, 2019 - 2022, USD Million
- TABLE 64 Spain Antacids Market by Mechanism of Action, 2023 - 2029, USD Million
- TABLE 65 Spain Antacids Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 66 Spain Antacids Market by Distribution Channel, 2023 - 2029, USD Million
- TABLE 67 Italy Antacids Market, 2019 - 2022, USD Million
- TABLE 68 Italy Antacids Market, 2023 - 2029, USD Million
- TABLE 69 Italy Antacids Market by Formulation Type, 2019 - 2022, USD Million
- TABLE 70 Italy Antacids Market by Formulation Type, 2023 - 2029, USD Million
- TABLE 71 Italy Antacids Market by Mechanism of Action, 2019 - 2022, USD Million
- TABLE 72 Italy Antacids Market by Mechanism of Action, 2023 - 2029, USD Million
- TABLE 73 Italy Antacids Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 74 Italy Antacids Market by Distribution Channel, 2023 - 2029, USD Million
- TABLE 75 Rest of Europe Antacids Market, 2019 - 2022, USD Million
- TABLE 76 Rest of Europe Antacids Market, 2023 - 2029, USD Million
- TABLE 77 Rest of Europe Antacids Market by Formulation Type, 2019 - 2022, USD Million
- TABLE 78 Rest of Europe Antacids Market by Formulation Type, 2023 - 2029, USD Million
- TABLE 79 Rest of Europe Antacids Market by Mechanism of Action, 2019 - 2022, USD Million
- TABLE 80 Rest of Europe Antacids Market by Mechanism of Action, 2023 - 2029, USD Million
- TABLE 81 Rest of Europe Antacids Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 82 Rest of Europe Antacids Market by Distribution Channel, 2023 - 2029, USD Million
- TABLE 83 Key Information - Abbott Laboratories
- TABLE 84 Key Information - Alkem Laboratories Ltd.
- TABLE 85 Key Information - Bayer AG
- TABLE 86 Key Information - Cipla Limited
- TABLE 87 Key Information - Pfizer, Inc.
- TABLE 88 Key Information - Prestige Consumer Healthcare, Inc.
- TABLE 89 Key information - Reckitt Benckiser Group PLC
- TABLE 90 Key Information - WellSpring Pharmaceutical Corporation
- TABLE 91 Key Information - Sanofi S.A.
- TABLE 92 Key Information - Sun Pharmaceutical Industries Ltd.
List of Figures
- FIG 1 Methodology for the research
- FIG 2 Europe Antacids Market share by Formulation Type, 2022
- FIG 3 Europe Antacids Market share by Formulation Type, 2029
- FIG 4 Europe Antacids Market by Formulation Type, 2019 - 2029, USD Million
- FIG 5 Europe Antacids Market share by Mechanism of Action, 2022
- FIG 6 Europe Antacids Market share by Mechanism of Action, 2029
- FIG 7 Europe Antacids Market by Mechanism of Action, 2019 - 2029, USD Million
- FIG 8 Europe Antacids Market share by Distribution Channel, 2022
- FIG 9 Europe Antacids Market share by Distribution Channel, 2029
- FIG 10 Europe Antacids Market by Distribution Channel, 2019 - 2029, USD Million
- FIG 11 Europe Antacids Market share by Country, 2022
- FIG 12 Europe Antacids Market share by Country, 2029
- FIG 13 Europe Antacids Market by Country, 2019 - 2029, USD Million
- FIG 14 Swot analysis: Abbott laboratories
- FIG 15 Swot analysis: bayer ag
